Zuellig issues all sorted out, wholesalers on free market competition.

Published: 2001-10-08 07:00:00

Updated: 2001-10-08 07:00:00

The Zuellig's issue was dramatically solved on Sept. 28 after almost 4 month long disputes, now, signaling an unlimited free competition in the Korean drug distribution market.

By an active intervention by the government the Zuellig management, the top executive members of the pharmaceutical m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK